3.8 Article

The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study

期刊

JMIR FORMATIVE RESEARCH
卷 6, 期 3, 页码 -

出版社

JMIR PUBLICATIONS, INC
DOI: 10.2196/32403

关键词

telemedicine; hypertension; blood pressure; quality of care; impact; COVID-19; cohort; cardiology; telehealth; retrospective

资金

  1. NewYork-Presbyterian Hospital Digital Health Operations Research Institute
  2. National Heart, Lung, and Blood Institute (NHLBI) [R01HL137818-03S1]
  3. American Heart Association [18AMFDP34380732]
  4. National Institutes of Health/NHLBI [K23HL141682, R01HL146636]
  5. Agency for Healthcare Research and Quality [T32HS026121]

向作者/读者索取更多资源

This study examines the association between telemedicine visits and blood pressure control quality measure. The results indicate that increased telemedicine visit use is associated with poor blood pressure control. However, telemedicine visit use may not negatively impact blood pressure control when blood pressure is recorded.
Background: Telemedicine visit use vastly expanded during the COVID-19 pandemic, and this has had an uncertain impact on cardiovascular care quality. Objective: We sought to examine the association between telemedicine visits and the failure to meet the Controlling High Blood Pressure (BP) quality measure from the Centers for Medicare & Medicaid Services. Methods: This was a retrospective cohort study of 32,727 adult patients with hypertension who were seen in primary care and cardiology clinics at an urban, academic medical center from February to December 2020. The primary outcome was a failure to meet the Controlling High Blood Pressure quality measure, which was defined as having no BP recorded or having a last recorded BP of =140/90 mm Hg (ie, poor BP control). Multivariable logistic regression was used to assess the association between telemedicine visit use during the study period (none, 1 telemedicine visit, or =2 telemedicine visits) and poor BP control; we adjusted for demographic and clinical characteristics. Results: During the study period, no BP was recorded for 2.3% (486/20,745) of patients with in-person visits only, 27.1% (1863/6878) of patients with 1 telemedicine visit, and 25% (1277/5104) of patients with =2 telemedicine visits. After adjustment, telemedicine use was associated with poor BP control (1 telemedicine visit: odds ratio [OR] 2.06, 95% CI 1.94-2.18; P<.001; =2 telemedicine visits: OR 2.49, 95% CI 2.31-2.68; P<.001; reference: in-person visits only). This effect disappeared when the analysis was restricted to patients with at least 1 recorded BP (1 telemedicine visit: OR 0.89, 95% CI 0.83-0.95; P=.001; =2 telemedicine visits: OR 0.91, 95% CI 0.83-0.99; P=.03). Conclusions: Increased telemedicine visit use is associated with poorer performance on the Controlling High Blood Pressure quality measure. However, telemedicine visit use may not negatively impact BP control when BP is recorded.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据